These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39421443)

  • 1. Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer institute.
    Vinante L; Vaidya JS; Caroli A; Mileto M; Piccoli E; Avanzo M; Barresi L; Marson M; Montico M; Baboci L; Perin T; Urbani M; Puglisi F; Mascarin M; Massarut S
    Front Oncol; 2024; 14():1424630. PubMed ID: 39421443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
    BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
    Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
    Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
    Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
    Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
    JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience.
    Brown A; Buss EJ; Chin C; Liu G; Lee S; Rao R; Taback B; Wiechmann L; Horowitz D; Choi JC; Katz LM; Connolly EP
    Front Oncol; 2022; 12():788213. PubMed ID: 35847872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
    Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
    Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.
    Valente SA; Tendulkar RD; Cherian S; Shah C; Ross DL; Lottich SC; Laronga C; Broman KK; Donnelly ED; Bethke KP; Shaw C; Lockney NA; Pederson A; Rudolph R; Hasselle M; Kelemen P; Hermanto U; Ashikari A; Kang S; Hoefer RA; McCready D; Fyles A; Escallon J; Rohatgi N; Graves J; Graves G; Willey SC; Tousimis E; Riley L; Deb N; Tu C; Small W; Grobmyer SR
    Ann Surg Oncol; 2021 May; 28(5):2512-2521. PubMed ID: 33433786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.
    Vaidya JS; Vaidya UJ; Baum M; Bulsara MK; Joseph D; Tobias JS
    Front Oncol; 2022; 12():786515. PubMed ID: 36033486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS
    Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
    Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
    Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Breast-Conserving Surgery with Synchronous 50-kV X-ray Intraoperative Partial Breast Irradiation in Patients Aged 64 Years or Older with Low-Risk Breast Cancer.
    Salari K; Glaza A; Lee JS; Sarvepalli N; Dekhne N; Kiran SH; Chen PY; Dilworth JT
    Breast Cancer (Auckl); 2024; 18():11782234231224267. PubMed ID: 38192516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative exploration of patients' experiences with Intrabeam TARGeted Intraoperative radioTherapy (TARGIT-IORT) and External-Beam RadioTherapy Treatment (EBRT) for breast cancer.
    Bagga SK; Swiderska N; Hooker C; Royle J; Ennis-O'Connor M; Freeney S; Watson D; Woolcock R; Lodge G; Laws S; Vaidya JS
    BMJ Open; 2024 Aug; 14(8):e081222. PubMed ID: 39164104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
    Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
    Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Conserving Surgery in Combination With Targeted Intraoperative Radiotherapy Compared to Mastectomy for In-breast-tumor-recurrence.
    Kolberg HC; Niesing H; Vaidya JS; Akpolat-Basci L; Maguz A; Hoffmann O; Loevey G; Stephanou M; Kolberg-Liedtke C
    Anticancer Res; 2023 Feb; 43(2):733-739. PubMed ID: 36697057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is IORT ready for roll-out?
    Esposito E; Anninga B; Honey I; Ross G; Rainsbury D; Laws S; Rinsma S; Douek M
    Ecancermedicalscience; 2015; 9():516. PubMed ID: 25793013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).
    Goerdt L; Schnaubelt R; Kraus-Tiefenbacher U; Brück V; Bauer L; Dinges S; von der Assen A; Meye H; Kaiser C; Weiss C; Clausen S; Schneider F; Abo-Madyan Y; Fleckenstein K; Berlit S; Tuschy B; Sütterlin M; Wenz F; Sperk E
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five Fraction Accelerated Partial Breast Irradiation Versus Intraoperative Radiation Therapy for Early-Stage Breast Cancer.
    Halima A; Parker S; Fane L; Sayed S; Hall EF; Obi E; Figueroa B; Al-Hilli Z; Valente S; Gentle C; Cherian S; Tendulkar R; Shah C
    Clin Breast Cancer; 2024 Jan; 24(1):79-84. PubMed ID: 37914593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.